SCHEMBL29014752

SCHEMBL29014752

O=C1NCC(C(=O)N[C@@H](c2ccc(Cl)cc2)c2cccc(F)c2F)O1

nearest known ligand 0.45

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
SCN8A Q9UQD0 6/20 0.45
DRD2 P14416 3/20 0.41
SRD5A2 P31213 1/20 0.35
SLC5A1 P13866 1/20 0.34
GAA P10253 1/20 0.34
CACNA2D1 P54289 1/20 0.34
CACNA1B Q00975 1/20 0.34
CACNB1 Q02641 1/20 0.34
HSD17B2 P37059 2/20 0.33
CNR2 P34972 1/20 0.33
P2RX7 Q99572 2/20 0.33
S1PR3 Q99500 2/20 0.32
S1PR1 P21453 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30502273 1.00 SCN8A (0.45) SCN8ADRD2SRD5A2SLC5A1GAA
SCHEMBL24124428 1.00 SCN8A (0.45) SCN8ADRD2SRD5A2SLC5A1GAA
SCHEMBL29014700 1.00 SCN8A (0.45) SCN8ADRD2SRD5A2SLC5A1GAA
SCHEMBL29014704 1.00 SCN8A (0.45) SCN8ADRD2SRD5A2SLC5A1GAA
SCHEMBL29014749 1.00 SCN8A (0.45) SCN8ADRD2SRD5A2SLC5A1GAA
SCHEMBL24124567 0.84 ALDH1A1 (0.45) SCN8ADRD2SRD5A2CACNA2D1CACNA1B
SCHEMBL30376333 0.84 ALDH1A1 (0.45) SCN8ADRD2SRD5A2CACNA2D1CACNA1B
SCHEMBL24124354 0.82 SCN8A (0.66) SCN8ASRD5A2SLC5A1CACNA2D1CACNA1B
SCHEMBL24124356 0.82 SCN8A (0.66) SCN8ASRD5A2SLC5A1CACNA2D1CACNA1B
SCHEMBL30376130 0.82 SCN8A (0.66) SCN8ASRD5A2SLC5A1CACNA2D1CACNA1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116056697-A 2-oxo-oxazolidine-5-carboxamides as NAV1.8 inhibitors 默沙东有限责任公司 2023-05-02 CN claimed
CN-116056697-A 2-oxo-oxazolidine-5-carboxamides as NAV1.8 inhibitors 默沙东有限责任公司 2023-05-02 CN disclosed